-
1
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
DOI 10.1056/NEJMoa043330
-
Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996. (Pubitemid 40349501)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van Den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.B.6
Belanger, K.7
Brandes, A.A.8
Marosi, C.9
Bogdahn, U.10
Curschmann, J.11
Janzer, R.C.12
Ludwin, S.K.13
Gorlia, T.14
Allgeier, A.15
Lacombe, D.16
Cairncross, J.G.17
Eisenhauer, E.18
Mirimanoff, R.O.19
-
2
-
-
70350461699
-
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
-
Friedman HS, Prados MD,Wen PY, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009;27(28):4733-4740.
-
(2009)
J Clin Oncol
, vol.27
, Issue.28
, pp. 4733-4740
-
-
Friedman, H.S.1
Prados, M.D.2
Wen, P.Y.3
-
3
-
-
0025281789
-
Response criteria for phase II studies of supratentorial malignant glioma
-
Macdonald D, Cascino T, Schold SJ, Cairncross J. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8(7):1277-1280. (Pubitemid 20195640)
-
(1990)
Journal of Clinical Oncology
, vol.8
, Issue.7
, pp. 1277-1280
-
-
Macdonald, D.R.1
Cascino, T.L.2
Schold Jr., S.C.3
Cairncross, J.G.4
-
4
-
-
84455185238
-
Pseudoprogressionandpseudoresponse: Imagingchallenges in the assessment of posttreatment glioma
-
Hygino da Cruz LC, Jr, Rodriguez I, Domingues RC, Gasparetto EL, SorensenAG. Pseudoprogressionandpseudoresponse: imagingchallenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol. 2011;32(11):1978- 1985.
-
(2011)
AJNR Am J Neuroradiol
, vol.32
, Issue.11
, pp. 1978-1985
-
-
Da Cruz Jr., H.L.C.1
Rodriguez, I.2
Domingues, R.C.3
Gasparetto, E.L.4
Sorensen, A.G.5
-
5
-
-
67649974030
-
End point assessment in gliomas: Novel treatments limit usefulness of classical Macdonald's criteria
-
van den Bent MJ, Vogelbaum MA,Wen PY, Macdonald DR, Chang SM. End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's criteria. J Clin Oncol. 2009;27(18):2905-2908.
-
(2009)
J Clin Oncol
, vol.27
, Issue.18
, pp. 2905-2908
-
-
Van Den Bent, M.J.1
Vogelbaum, M.A.2
Wen, P.Y.3
Macdonald, D.R.4
Chang, S.M.5
-
6
-
-
74049087788
-
Pseudoprogression and pseudoresponse in the treatment of gliomas
-
Brandsma D, van den Bent MJ. Pseudoprogression and pseudoresponse in the treatment of gliomas. Curr Opin Neurol. 2009;22(6):633-638. Review.
-
(2009)
Curr Opin Neurol
, vol.22
, Issue.6
, pp. 633-638
-
-
Brandsma, D.1
Van Den Bent, M.J.2
-
7
-
-
77951625266
-
Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology working group
-
Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology working group. J Clin Oncol. 2010;28(11):1963-1972.
-
(2010)
J Clin Oncol
, vol.28
, Issue.11
, pp. 1963-1972
-
-
Wen, P.Y.1
Macdonald, D.R.2
Reardon, D.A.3
-
8
-
-
20044366017
-
Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema
-
DOI 10.1002/jmri.20335
-
Oh J, Cha S, Aiken, et al. Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging. 2005;21(6): 701-708. (Pubitemid 40770861)
-
(2005)
Journal of Magnetic Resonance Imaging
, vol.21
, Issue.6
, pp. 701-708
-
-
Oh, J.1
Cha, S.2
Aiken, A.H.3
Han, E.T.4
Crane, J.C.5
Stainsby, J.A.6
Wright, G.A.7
Dillon, W.P.8
Nelson, S.J.9
-
9
-
-
0027008434
-
2 relaxation of experimental brain tumors in the cat: A multiparameter tissue characterization
-
DOI 10.1016/0730-725X(92)90448-9
-
Hoehn-Berlage M, Tolxdorff T, Bockhorst K, Okada Y, Ernestus RI. In vivo NMRT2 relaxation of experimental brain tumors in the cat: a multiparameter tissue characterization. Magn Reson Imaging. 1992;10(6):935-947. (Pubitemid 23082027)
-
(1992)
Magnetic Resonance Imaging
, vol.10
, Issue.6
, pp. 935-947
-
-
Hoehn-Berlage, M.1
Tolxdorff, T.2
Bockhorst, K.3
Okada, Y.4
Ernestus, R.-I.5
-
10
-
-
0028839868
-
High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat
-
EisM,Els T,Hoehn-BerlageM.High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat. Magn Reson Med. 1995;34(6):835-844.
-
(1995)
Magn Reson Med
, vol.34
, Issue.6
, pp. 835-844
-
-
Eis, M.1
Els, T.2
Hoehn-Berlage, M.3
-
11
-
-
83055181491
-
Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab
-
Ellingson BM, Cloughesy TF, Lai A, et al. Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2012;106(1):111-119.
-
(2012)
J Neurooncol
, vol.106
, Issue.1
, pp. 111-119
-
-
Ellingson, B.M.1
Cloughesy, T.F.2
Lai, A.3
-
12
-
-
84856302564
-
Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: A 31P/1H MRSI and quantitative magnetic resonance imaging study
-
Hattingen E, Jurcoane A, Bähr O, et al. Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study. Neuro Oncol. 2011;13(12):1349-1363.
-
(2011)
Neuro Oncol
, vol.13
, Issue.12
, pp. 1349-1363
-
-
Hattingen, E.1
Jurcoane, A.2
Baöhr, O.3
-
13
-
-
80052965850
-
Quantitative T 2-mapping based on multi-slice multiple gradient echo flash imaging: Retrospective correction for subject motion effects
-
Magerkurth J, Volz S, Wagner M, et al. Quantitative T*2-mapping based on multi-slice multiple gradient echo flash imaging: retrospective correction for subject motion effects. Magn Reson Med. 2011;66(4): 989-997.
-
(2011)
Magn Reson Med
, vol.66
, Issue.4
, pp. 989-997
-
-
Magerkurth, J.1
Volz, S.2
Wagner, M.3
-
14
-
-
79954441652
-
Signal intensity in T2? Magnetic resonance imaging is related to brain glioma grade
-
Saitta L, Heese O, FörsterAF, Matschke J, et al. Signal intensity in T2? magnetic resonance imaging is related to brain glioma grade. Eur Radiol. 2011;21(5):1068-1076.
-
(2011)
Eur Radiol
, vol.21
, Issue.5
, pp. 1068-1076
-
-
Saitta, L.1
Heese, O.2
Förster, A.F.3
Matschke, J.4
-
15
-
-
0025336246
-
Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields
-
DOI 10.1002/mrm.1910140108
-
Ogawa S, Lee TM, Nayak AS, Glynn P. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med. 1990;14(1):68-78. (Pubitemid 20243866)
-
(1990)
Magnetic Resonance in Medicine
, vol.14
, Issue.1
, pp. 68-78
-
-
Ogawa, S.1
Lee, T.-M.2
Nayak, A.S.3
Glynn, P.4
-
16
-
-
84862979110
-
FSL
-
Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. Neuroimage. 2012;62(2):782-790.
-
(2012)
Neuroimage
, vol.62
, Issue.2
, pp. 782-790
-
-
Jenkinson, M.1
Beckmann, C.F.2
Behrens, T.E.3
Woolrich, M.W.4
Smith, S.M.5
-
17
-
-
33644847163
-
MR imaging correlates of survival in patients with high-grade gliomas
-
Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF.MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol. 2005;26(10):2466-2474.
-
(2005)
AJNR Am J Neuroradiol
, vol.26
, Issue.10
, pp. 2466-2474
-
-
Pope, W.B.1
Sayre, J.2
Perlina, A.3
Villablanca, J.P.4
Mischel, P.S.5
Cloughesy, T.F.6
-
18
-
-
53749087689
-
Relationship between gene expression and enhancement in glioblastoma multiforme: Exploratory DNA microarray analysis
-
Pope WB, Chen JH, Dong J, et al. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. Radiology. 2008;249(1):268-277.
-
(2008)
Radiology
, vol.249
, Issue.1
, pp. 268-277
-
-
Pope, W.B.1
Chen, J.H.2
Dong, J.3
-
20
-
-
0032914675
-
NMR relaxation times in the human brain at 3.0 Tesla
-
DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L
-
Wansapura JP, Holland SK, Dunn RS, Ball WS Jr. NMR relaxation times in the human brain at 3.0 tesla. J Magn Reson Imaging. 1999;(4):531-538. (Pubitemid 29194290)
-
(1999)
Journal of Magnetic Resonance Imaging
, vol.9
, Issue.4
, pp. 531-538
-
-
Wansapura, J.P.1
Holland, S.K.2
Dunn, R.S.3
Ball Jr., W.S.4
-
21
-
-
79956061552
-
Response assessment in neuro-oncology criteria: Implementation challenges in multicenter neuro-oncology trials
-
Pope WB, Hessel C. Response assessment in neuro-oncology criteria: implementation challenges in multicenter neuro-oncology trials. AJNRAmJ Neuroradiol. 2011;32(5):794-797.
-
(2011)
AJNRAmJ Neuroradiol
, vol.32
, Issue.5
, pp. 794-797
-
-
Pope, W.B.1
Hessel, C.2
-
22
-
-
0035142330
-
Effect of T1 relaxation time on lesion contrast enhancement in flair MR imaging: A study using computer-generated brain maps
-
Melhem ER, Itoh R. Effect of T1 relaxation time on lesion contrast enhancement in FLAIR MR imaging: a study using computer-generated brain maps. AJR Am J Roentgenol. 2001;176(2):537-539. (Pubitemid 32105678)
-
(2001)
American Journal of Roentgenology
, vol.176
, Issue.2
, pp. 537-539
-
-
Melhem, E.R.1
Itoh, R.2
-
23
-
-
79952740612
-
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma
-
Keunen O, Johansson M, Oudin A, et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci U S A. 2011;108(9):3749-3754.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, Issue.9
, pp. 3749-3754
-
-
Keunen, O.1
Johansson, M.2
Oudin, A.3
-
24
-
-
78651408563
-
Glioblastoma recurrence after cediranib therapy in patients: Lack of 'rebound' revascularization as mode of escape
-
di Tomaso E, Snuderl M, Kamoun WS, et al. Glioblastoma recurrence after cediranib therapy in patients: lack of 'rebound' revascularization as mode of escape. Cancer Res. 2011;71(1):19-28.
-
(2011)
Cancer Res
, vol.71
, Issue.1
, pp. 19-28
-
-
Di Tomaso, E.1
Snuderl, M.2
Kamoun, W.S.3
-
25
-
-
84899833526
-
Bevacizumab failure in glioblastomas [Meeting Abstracts
-
Tabatabai G, Felsberg J, Sabel M, et al. Bevacizumab failure in glioblastomas [Meeting Abstracts]. J Clin Oncol. 2012;30(15):2067.
-
(2012)
J Clin Oncol
, vol.30
, Issue.15
, pp. 2067
-
-
Tabatabai, G.1
Felsberg, J.2
Sabel, M.3
|